Please login to the form below

Not currently logged in
Email:
Password:

bedaquiline

This page shows the latest bedaquiline news and features for those working in and with pharma, biotech and healthcare.

J&J pledges $500m investment into HIV and tuberculosis R&D

J&J pledges $500m investment into HIV and tuberculosis R&D

In the TB therapy area, J&J will work with partners to improve detection methods for undiagnosed cases of the disease, and broaden the access to its targeted TB medicine bedaquiline –

Latest news

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • The world is our laboratory The world is our laboratory

    We developed Sirturo (bedaquiline), the first new medicine for tuberculosis in 40 years, which received the UK Prix Galien Award for most innovative orphan drug in October 2014.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...
Pills
Tackling antimicrobial resistance on multiple fronts
An urgent change of direction is needed in how we respond to AMR...

Infographics